Benitec Biopharma
$2.829876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$2.82
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.14 (+5.20%) Today
-$0.01 (-0.35%) As of 8:00 PM EST after-hours
Why Robinhood?
You can buy or sell BNTC and other stocks, options, and ETFs commission-free!
About BNTC
Benitec Biopharma, Inc. engages in the discovery, development, and commercialization of therapeutic agents by applying the silence and replace approach to the treatment of genetic disorders. It is a development-stage biotechnology company which focuses on the advancement of novel genetic medicines. The company is headquartered in Hayward, CA. The listed name for BNTC is Benitec Biopharma Inc. Common Stock.
CEO
Jerel A. Banks
Employees
—
Headquarters
Hayward, California
Founded
—
Market Cap
4.55M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
916.87K
High Today
$2.85
Low Today
$2.68
Open Price
$2.73
Volume
219.75K
52 Week High
$17.39
52 Week Low
$2.52
Collections
BNTC Earnings
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Estimated
— per share
Actual
Expected Nov 17, Pre-Market